Description

Furo[2,3-B]Pyridin-4(7H)-One, 3-(4-Fluorophenyl)-7-Methyl-2-Phenyl- is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily sought by research institutions and manufacturers in the pharmaceutical and biotechnology sectors engaged in drug discovery and development programs.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of complex drug candidates, especially those targeting central nervous system (CNS) disorders, oncology, or inflammatory diseases.
• Medicinal Chemistry Research: Used as a versatile scaffold for structure-activity relationship (SAR) studies and library synthesis in early-stage drug discovery.
• API Development: Integral to the process development and scale-up of new chemical entities (NCEs) due to its fused furopyridinone core.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process optimization for client molecules.
• Academic Research: Utilized in university and institutional labs for studying heterocyclic chemistry, reaction mechanisms, and developing new synthetic methodologies.

Basic Information

Product Name	Furo[2,3-B]Pyridin-4(7H)-One, 3-(4-Fluorophenyl)-7-Methyl-2-Phenyl-
CAS No.	571169-08-9
Molecular Formula	C20H14FNO2
Molecular Weight	319.33 g/mol
Synonyms	3-(4-Fluorophenyl)-7-methyl-2-phenylfuro[2,3-b]pyridin-4(7H)-one; 4(7H)-Furo[2,3-b]pyridinone, 3-(4-fluorophenyl)-7-methyl-2-phenyl-; 3-(p-Fluorophenyl)-7-methyl-2-phenylfuro[2,3-b]pyridin-4-one; 571169-08-9; Furo[2,3-b]pyridine-4(7H)-one derivative
EINECS	Contact for details

Quality Control

Our Furo[2,3-B]Pyridin-4(7H)-One intermediate is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and residual solvent analysis, to ensure it meets the exacting standards required for pharmaceutical R&D and production. Certificates of Analysis (COA) with full traceability are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider an inert atmosphere to preserve stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.